🇺🇸 FDA
Company

KIORA

KIORA PHARMACEUTICALS INC

KPRX pharma USA

Quick answer

KIORA is a pharma company (KPRX) headquartered in ENCINITAS, CA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

100 μg KIO-301

Retinitis Pigmentosa

Phase 2 · small_molecule · active

1 trials project

KIO-101

Dry Eye Disease

Phase 2 · small_molecule · terminated

1 trials project

KIO-104

Macular Edema

Phase 2 · small_molecule · active

1 trials project

KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)

Persistent Corneal Epithelial Defect

Phase 2 · small_molecule · completed

1 trials project

KIO-301

Retinitis Pigmentosa

Phase 2 · small_molecule · completed

1 trials

Patents (4)

patent

US 12364680

Compounds for treating ophthalmic diseases and disorders

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12209073

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11730716

Compounds for treating ophthalmic diseases and disorders

Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11376214

Compositions and methods for treatment of ocular diseases

Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)